{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T01:05:15Z","timestamp":1784941515703,"version":"3.55.0"},"reference-count":65,"publisher":"Oxford University Press (OUP)","issue":"Supplement_1","license":[{"start":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T00:00:00Z","timestamp":1771891200000},"content-version":"vor","delay-in-days":9,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Enhancing Public Health Capabilities and Increasing Capacity"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,2,24]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>This supplement review article discusses recent advancements in Chlamydia trachomatis and Neisseria gonorrhoeae detection methods, addressing key questions related to laboratory-based molecular methods, point-of-care testing, culture, and resistance detection. Each manuscript in this supplement summarizes available test methods and their performance characteristics. Additionally, current challenges and research gaps are described. Emerging technologies, such as molecular point-of-care tests and self-collection kits, are highlighted for their potential to improve accessibility, accuracy, and patient-centered care<\/jats:p>","DOI":"10.1093\/cid\/ciaf665","type":"journal-article","created":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T13:00:29Z","timestamp":1764680429000},"page":"S1-S5","source":"Crossref","is-referenced-by-count":1,"title":["Evidence Review for Centers for Disease Control and Prevention Guidance Development on the Detection of\n                    <i>Chlamydia trachomatis<\/i>\n                    and\n                    <i>Neisseria gonorrhoeae<\/i>"],"prefix":"10.1093","volume":"82","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5698-872X","authenticated-orcid":false,"given":"Amanda C","family":"Smith","sequence":"first","affiliation":[{"name":"Division of STD Prevention, National Center for HIV, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention , Atlanta, Georgia, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3819-0324","authenticated-orcid":false,"given":"Ellen N","family":"Kersh","sequence":"additional","affiliation":[{"name":"Division of STD Prevention, National Center for HIV, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention , Atlanta, Georgia, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,2,24]]},"reference":[{"key":"2026022409275732700_ciaf665-B1"},{"key":"2026022409275732700_ciaf665-B2"},{"key":"2026022409275732700_ciaf665-B3"},{"key":"2026022409275732700_ciaf665-B4"},{"key":"2026022409275732700_ciaf665-B5","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/S0091-7435(02)00058-0","article-title":"Asymptomatic sexually transmitted diseases: the case for screening","volume":"36","author":"Farley","year":"2003","journal-title":"Prev Med"},{"key":"2026022409275732700_ciaf665-B6","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1258\/0956462021924712","article-title":"What proportion of episodes of gonorrhoea and chlamydia becomes symptomatic","volume":"13","author":"Korenromp","year":"2002","journal-title":"Int J STD AIDS"},{"key":"2026022409275732700_ciaf665-B7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr7302a1","article-title":"CDC clinical guidelines on the use of doxycycline postexposure prophylaxis for bacterial sexually transmitted infection prevention, United States, 2024","volume":"73","author":"Bachmann","year":"2024","journal-title":"MMWR Recomm Rep"},{"key":"2026022409275732700_ciaf665-B8","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1093\/infdis\/jiae383","article-title":"Effectiveness of MenB-4C vaccine against gonorrhea: a systematic review and meta-analysis","volume":"231","author":"Abara","year":"2025","journal-title":"J Infect Dis"},{"issue":"No. RR-12","key":"2026022409275732700_ciaf665-B9","first-page":"1","article-title":"Recommendations for the prevention and management of Chlamydia trachomatis infections, 1993","volume":"42","author":"CDC","year":"1993","journal-title":"MMWR Recomm Rep"},{"key":"2026022409275732700_ciaf665-B10","first-page":"1","article-title":"Screening tests to detect Chlamydia trachomatis and Neisseria gonorrhoeae infections\u20142002","volume":"51","author":"Johnson","year":"2002","journal-title":"MMWR Recomm Rep"},{"key":"2026022409275732700_ciaf665-B11","first-page":"1","article-title":"Recommendations for the laboratory-based detection of Chlamydia trachomatis and Neisseria gonorrhoeae\u20142014","volume":"63","author":"Papp","year":"2014","journal-title":"MMWR Recomm Rep"},{"key":"2026022409275732700_ciaf665-B12","volume-title":"Laboratory and point-of-care diagnostic testing for sexually transmitted infections, including HIV","author":"WHO","year":"2023","edition":"1st ed"},{"key":"2026022409275732700_ciaf665-B13","doi-asserted-by":"crossref","first-page":"e0136321","DOI":"10.1128\/JCM.01363-21","article-title":"Multicenter comparison of nucleic acid amplification tests for the diagnosis of rectal and oropharyngeal Chlamydia trachomatis and Neisseria gonorrhoeae infections","volume":"60","author":"Van Der Pol","year":"2022","journal-title":"J Clin Microbiol"},{"key":"2026022409275732700_ciaf665-B14","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1128\/JCM.01581-08","article-title":"Nucleic acid amplification tests for diagnosis of Neisseria gonorrhoeae oropharyngeal infections","volume":"47","author":"Bachmann","year":"2009","journal-title":"J Clin Microbiol"},{"key":"2026022409275732700_ciaf665-B15","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1128\/JCM.02398-09","article-title":"Nucleic acid amplification tests for diagnosis of Neisseria gonorrhoeae and Chlamydia trachomatis rectal infections","volume":"48","author":"Bachmann","year":"2010","journal-title":"J Clin Microbiol"},{"key":"2026022409275732700_ciaf665-B16","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1097\/OLQ.0000000000000627","article-title":"Comparative evaluation of 2 nucleic acid amplification tests for the detection of Chlamydia trachomatis and Neisseria gonorrhoeae at extragenital sites","volume":"44","author":"Bristow","year":"2017","journal-title":"Sex Transm Dis"},{"key":"2026022409275732700_ciaf665-B17","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1556\/1886.2017.00018","article-title":"High-throughput testing of urogenital and extragenital specimens for detection of Chlamydia trachomatis and Neisseria gonorrhoeae with Cobas\u00ae CT\/NG","volume":"7","author":"Marlowe","year":"2017","journal-title":"Eur J Microbiol Immunol (Bp)"},{"key":"2026022409275732700_ciaf665-B18","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.1093\/cid\/ciz1105","article-title":"Simultaneous evaluation of diagnostic assays for pharyngeal and rectal Neisseria gonorrhoeae and Chlamydia trachomatis using a master protocol","volume":"71","author":"Doernberg","year":"2020","journal-title":"Clin Infect Dis"},{"key":"2026022409275732700_ciaf665-B19","doi-asserted-by":"crossref","first-page":"2801","DOI":"10.1128\/JCM.00616-17","article-title":"Use of nucleic acid amplification testing for diagnosis of extragenital sexually transmitted infections","volume":"55","author":"Cosentino","year":"2017","journal-title":"J Clin Microbiol"},{"key":"2026022409275732700_ciaf665-B20","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.jmoldx.2020.03.004","article-title":"Analytical evaluation of the Abbott RealTime CT\/NG assay for detection of Chlamydia trachomatis and Neisseria gonorrhoeae in rectal and pharyngeal swabs","volume":"22","author":"Adamson","year":"2020","journal-title":"J Mol Diagn"},{"key":"2026022409275732700_ciaf665-B21"},{"key":"2026022409275732700_ciaf665-B22","author":"Molecular"},{"key":"2026022409275732700_ciaf665-B23","first-page":"1855","article-title":"FDA clears first at-home test for chlamydia, gonorrhea, and trichomoniasis","volume":"333","author":"Anderer","year":"2025","journal-title":"JAMA"},{"key":"2026022409275732700_ciaf665-B24","doi-asserted-by":"crossref","first-page":"1900298","DOI":"10.2807\/1560-7917.ES.2019.24.22.1900298","article-title":"Chlamydia trachomatis samples testing falsely negative in the Aptima Combo 2 test in Finland, 2019","volume":"24","author":"Rantakokko-Jalava","year":"2019","journal-title":"Euro Surveill"},{"key":"2026022409275732700_ciaf665-B25","doi-asserted-by":"crossref","first-page":"227","DOI":"10.3390\/microorganisms7080227","article-title":"The Finnish new variant of Chlamydia trachomatis with a single nucleotide polymorphism in the 23S rRNA target escapes detection by the Aptima Combo 2 test","volume":"7","author":"Hokynar","year":"2019","journal-title":"Microorganisms"},{"key":"2026022409275732700_ciaf665-B26","doi-asserted-by":"crossref","first-page":"1900370","DOI":"10.2807\/1560-7917.ES.2019.24.26.1900370","article-title":"Finnish new variant of Chlamydia trachomatis escaping detection in the Aptima Combo 2 assay also present in \u00d6rebro county, Sweden, may 2019","volume":"24","author":"Unemo","year":"2019","journal-title":"Euro Surveill"},{"key":"2026022409275732700_ciaf665-B27","doi-asserted-by":"crossref","first-page":"3610","DOI":"10.1128\/JCM.01217-11","article-title":"Evaluation of six commercial nucleic acid amplification tests for detection of Neisseria gonorrhoeae and other Neisseria species","volume":"49","author":"Tabrizi","year":"2011","journal-title":"J Clin Microbiol"},{"key":"2026022409275732700_ciaf665-B28","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1128\/JCM.02137-20","article-title":"Despite excellent test characteristics of the cobas 4800 CT\/NG assay, detection of oropharyngeal Chlamydia trachomatis and Neisseria gonorrhoeae remains challenging","volume":"59","author":"van Niekerk","year":"2021","journal-title":"J Clin Microbiol"},{"key":"2026022409275732700_ciaf665-B29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr7004a1","article-title":"Sexually transmitted infections treatment guidelines, 2021","volume":"70","author":"Workowski","year":"2021","journal-title":"MMWR Recomm Rep"},{"key":"2026022409275732700_ciaf665-B30","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.3201\/eid1108.050535","article-title":"Real-time polymerase chain reaction to diagnose lymphogranuloma venereum","volume":"11","author":"Morr\u00e9","year":"2005","journal-title":"Emerg Infect Dis"},{"key":"2026022409275732700_ciaf665-B31","doi-asserted-by":"crossref","first-page":"e0233990","DOI":"10.1371\/journal.pone.0233990","article-title":"Reduction of non-typeable results using a plasmid oriented lymfogranuloma venereum PCR for typing of Chlamydia trachomatis positive samples","volume":"15","author":"Smit","year":"2020","journal-title":"PLoS One"},{"key":"2026022409275732700_ciaf665-B32","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1097\/OLQ.0000000000001120","article-title":"Evaluation of 2 commercial assays for the detection of lymphogranuloma venereum in rectal samples","volume":"47","author":"Bernal-Mart\u00ednez","year":"2020","journal-title":"Sex Transm Dis"},{"key":"2026022409275732700_ciaf665-B33","doi-asserted-by":"crossref","first-page":"909.e1","DOI":"10.1016\/j.cmi.2020.07.040","article-title":"Evaluation of four commercial real-time PCR assays for the detection of lymphogranuloma venereum in Chlamydia trachomatis-positive anorectal samples","volume":"27","author":"Touati","year":"2021","journal-title":"Clin Microbiol Infect"},{"key":"2026022409275732700_ciaf665-B34","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/j.jemermed.2017.08.094","article-title":"Reliable rapid assay for gonorrhea and chlamydia in the emergency department","volume":"53","author":"Wilson","year":"2017","journal-title":"J Emerg Med"},{"key":"2026022409275732700_ciaf665-B35","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.nurpra.2020.01.006","article-title":"Getting it right: the impact of point-of-care testing for gonorrhea and chlamydia in the urgent care setting","volume":"16","author":"Fisk","year":"2020","journal-title":"J Nurse Pract"},{"key":"2026022409275732700_ciaf665-B36","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1097\/OLQ.0000000000001586","article-title":"Clinical integration of a highly accurate polymerase chain reaction point-of-care test can inform immediate treatment decisions for chlamydia, gonorrhea, and trichomonas","volume":"49","author":"Dawkins","year":"2022","journal-title":"Sex Transm Dis"},{"key":"2026022409275732700_ciaf665-B37","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1097\/OLQ.0000000000000438","article-title":"A randomized controlled trial comparing the treatment of patients tested for chlamydia and gonorrhea after a rapid polymerase chain reaction test versus standard of care testing","volume":"43","author":"May","year":"2016","journal-title":"Sex Transm Dis"},{"key":"2026022409275732700_ciaf665-B38","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1097\/OLQ.0000000000000865","article-title":"Performance of the atlas genetics rapid test for Chlamydia trachomatis and women's attitudes toward point-of-care testing","volume":"45","author":"Widdice","year":"2018","journal-title":"Sex Transm Dis"},{"key":"2026022409275732700_ciaf665-B39","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1097\/OLQ.0000000000001995","article-title":"An evaluation of the performance, patient acceptability, and feasibility of a point-of-care HIV-syphilis assay in an urban emergency department","volume":"51","author":"Maliszewski","year":"2024","journal-title":"Sex Transm Dis"},{"key":"2026022409275732700_ciaf665-B40","doi-asserted-by":"crossref","first-page":"e0237424","DOI":"10.1371\/journal.pone.0237424","article-title":"Developing target product profiles for Neisseria gonorrhoeae diagnostics in the context of antimicrobial resistance: an expert consensus","volume":"15","author":"Ferreyra","year":"2020","journal-title":"PLoS One"},{"key":"2026022409275732700_ciaf665-B41","doi-asserted-by":"crossref","first-page":"000204","DOI":"10.1099\/acmi.0.000204","article-title":"Chlamydial clinical isolates show subtle differences in persistence phenotypes and growth in vitro","volume":"3","author":"Thomas","year":"2021","journal-title":"Access microbiol"},{"key":"2026022409275732700_ciaf665-B42","doi-asserted-by":"crossref","first-page":"656","DOI":"10.2741\/4611","article-title":"Molecular mechanisms of Chlamydia trachomatis resistance to antimicrobial drugs","volume":"23","author":"Mestrovic","year":"2018","journal-title":"Front Biosci (Landmark Ed)"},{"key":"2026022409275732700_ciaf665-B43","doi-asserted-by":"crossref","first-page":"975","DOI":"10.3390\/antibiotics12060975","article-title":"Phenotypic and genotypic antimicrobial susceptibility testing of Chlamydia trachomatis isolates from patients with persistent or clinical treatment failure in Spain","volume":"12","author":"Villa","year":"2023","journal-title":"Antibiotics (Basel)"},{"key":"2026022409275732700_ciaf665-B44","doi-asserted-by":"crossref","first-page":"3101","DOI":"10.3389\/fmicb.2018.03101","article-title":"Chlamydia persistence: a survival strategy to evade antimicrobial effects in-vitro and in-vivo","volume":"9","author":"Panzetta","year":"2018","journal-title":"Front Microbiol"},{"key":"2026022409275732700_ciaf665-B45","doi-asserted-by":"crossref","first-page":"e3196","DOI":"10.1093\/cid\/ciaa1089","article-title":"Performance of patient-collected specimens for Neisseria gonorrhoeae culture","volume":"73","author":"Barbee","year":"2021","journal-title":"Clin Infect Dis"},{"key":"2026022409275732700_ciaf665-B46","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.diagmicrobio.2016.06.019","article-title":"Recovery of Neisseria gonorrhoeae from 4 commercially available transport systems","volume":"86","author":"Papp","year":"2016","journal-title":"Diagn Microbiol Infect Dis"},{"key":"2026022409275732700_ciaf665-B47","doi-asserted-by":"crossref","first-page":"e0259668","DOI":"10.1371\/journal.pone.0259668","article-title":"72-Hour transport recovery of antimicrobial resistant Neisseria gonorrhoeae isolates using the InTray\u00ae GC method","volume":"17","author":"Paris","year":"2022","journal-title":"PLoS One"},{"key":"2026022409275732700_ciaf665-B48","first-page":"216","article-title":"Comparison of deferred and bedside culture of Neisseria gonorrhoeae: a study to improve the isolation of gonococci for antimicrobial susceptibility testing","volume":"12","author":"Boiko","year":"2020","journal-title":"Iran J Microbiol"},{"key":"2026022409275732700_ciaf665-B49","doi-asserted-by":"crossref","first-page":"246","DOI":"10.18683\/germs.2021.1261","article-title":"Comparative performance of commercial Amies transport media with and without charcoal for Neisseria gonorrhoeae culture for gonococcal isolation and antimicrobial resistance monitoring in Ukraine","volume":"11","author":"Boiko","year":"2021","journal-title":"Germs"},{"key":"2026022409275732700_ciaf665-B50","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.mimet.2017.12.012","article-title":"Preservation of Neisseria gonorrhoeae: should swabs be refrigerated or not?","volume":"145","author":"Serra-Pladevall","year":"2018","journal-title":"J Microbiol Methods"},{"key":"2026022409275732700_ciaf665-B51","first-page":"96","article-title":"Evaluation of the Copan eSwab\u00ae, a liquid-based microbiology transport system, for the preservation of Neisseria gonorrhoeae at different temperatures","volume":"32","author":"Gumede","year":"2017","journal-title":"S Afr J Infect Dis"},{"key":"2026022409275732700_ciaf665-B52","doi-asserted-by":"crossref","first-page":"e0057522","DOI":"10.1128\/jcm.00575-22","article-title":"Meningococcal urethritis: old and new","volume":"60","author":"Burns","year":"2022","journal-title":"J Clin Microbiol"},{"key":"2026022409275732700_ciaf665-B53","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1099\/jmm.0.059378-0","article-title":"A misleading urethral smear with polymorphonuclear leucocytes and intracellular diplococci; case report of urethritis caused by Neisseria meningitidis","volume":"62","author":"Genders","year":"2013","journal-title":"J Med Microbiol"},{"key":"2026022409275732700_ciaf665-B54","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1093\/cid\/cix215","article-title":"Large cluster of Neisseria meningitidis urethritis in Columbus, Ohio, 2015","volume":"65","author":"Bazan","year":"2017","journal-title":"Clin Infect Dis"},{"key":"2026022409275732700_ciaf665-B55","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1007\/s10096-018-3368-6","article-title":"Use of Andromas and Bruker MALDI-TOF MS in the identification of Neisseria","volume":"37","author":"Morel","year":"2018","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"2026022409275732700_ciaf665-B56","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1186\/s12866-015-0480-y","article-title":"Evaluation of matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS) for identification and clustering of Neisseria gonorrhoeae","volume":"15","author":"Carannante","year":"2015","journal-title":"BMC Microbiol"},{"key":"2026022409275732700_ciaf665-B57","doi-asserted-by":"crossref","DOI":"10.1099\/jmm.0.001871","article-title":"Genomic oropharyngeal Neisseria surveillance detects MALDI-TOF MS species misidentifications and reveals a novel Neisseria cinerea clade","volume":"73","author":"de Block","year":"2024","journal-title":"J Med Microbiol"},{"key":"2026022409275732700_ciaf665-B58","doi-asserted-by":"crossref","first-page":"2270","DOI":"10.1128\/JCM.00664-14","article-title":"Misidentification of Neisseria polysaccharea as Neisseria meningitidis with the use of matrix-assisted laser desorption ionization-time of flight mass spectrometry","volume":"52","author":"Cunningham","year":"2014","journal-title":"J Clin Microbiol"},{"key":"2026022409275732700_ciaf665-B59","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.cmi.2018.09.015","article-title":"Identification of Neisseria meningitidis by MALDI-TOF MS may not be reliable","volume":"25","author":"Hong","year":"2019","journal-title":"Clin Microbiol Infect"},{"key":"2026022409275732700_ciaf665-B60","doi-asserted-by":"crossref","first-page":"S78","DOI":"10.1097\/OLQ.0000000000001471","article-title":"Genomic analysis of the predominant strains and antimicrobial resistance determinants within 1479 Neisseria gonorrhoeae isolates from the US gonococcal isolate surveillance project in 2018","volume":"48","author":"Reimche","year":"2021","journal-title":"Sex Transm Dis"},{"key":"2026022409275732700_ciaf665-B61","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1007\/s10096-025-05053-4","article-title":"Evaluation of the Allplex NG & DR assay for molecular prediction of ciprofloxacin and azithromycin resistance in Neisseria gonorrhoeae","volume":"44","author":"Roditscheff","year":"2025","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"2026022409275732700_ciaf665-B62","doi-asserted-by":"crossref","first-page":"115262","DOI":"10.1016\/j.diagmicrobio.2020.115262","article-title":"Evaluation of the molecular detection of ciprofloxacin resistance in Neisseria gonorrhoeae by the ResistancePlus GC assay (SpeeDx)","volume":"99","author":"Cotton","year":"2021","journal-title":"Diagn Microbiol Infect Dis"},{"key":"2026022409275732700_ciaf665-B63","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1093\/jac\/dkz108","article-title":"Evaluation of the ResistancePlus GC (beta) assay: a commercial diagnostic test for the direct detection of ciprofloxacin susceptibility or resistance in Neisseria gonorrhoeae","volume":"74","author":"Ebeyan","year":"2019","journal-title":"J Antimicrob Chemother"},{"key":"2026022409275732700_ciaf665-B64","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1093\/cid\/ciaa596","article-title":"Resistance-guided treatment of gonorrhea: a prospective clinical study","volume":"73","author":"Klausner","year":"2021","journal-title":"Clin Infect Dis"},{"key":"2026022409275732700_ciaf665-B65","doi-asserted-by":"crossref","first-page":"e00089-21","DOI":"10.1128\/JCM.00089-21","article-title":"Reflex detection of ciprofloxacin resistance in Neisseria gonorrhoeae by use of the SpeeDx ResistancePlus GC assay","volume":"59","author":"Lee","year":"2021","journal-title":"J Clin Microbiol"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/82\/Supplement_1\/S1\/67091313\/ciaf665.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/82\/Supplement_1\/S1\/67091313\/ciaf665.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T14:28:13Z","timestamp":1771943293000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article\/82\/Supplement_1\/S1\/8496025"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,15]]},"references-count":65,"journal-issue":{"issue":"Supplement_1","published-online":{"date-parts":[[2026,2,24]]},"published-print":{"date-parts":[[2026,2,24]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/ciaf665","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,2,15]]},"published":{"date-parts":[[2026,2,15]]}}}